glp 1 gip receptor agonist Major physiological roles of GLP-1 and GIP. Tirzepatide is acting as an New Developments in Pharmacological Treatment

An alternative suggestion was that for patients with symptoms suggesting retained gastric contents, for whom delaying endoscopy may have negative clinical consequences, rapid-sequence intubation should be considered

GLP-1 receptor agonists produce modest but meaningful improvements in cholesterol and triglyceride levels, though lipid reduction is not their primary indication

[DOI] [PMC free article] [PubMed] [Google Scholar] 107.Sorli C., et al

It is the first triple-hormone receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously, a mechanism that produced 24.2% mean body weight reduction in Phase 2 trials and a staggering 28.7% in Phase 3 data

Currently, GLP-1 receptor agonists should only be used for FDA-approved indications such as type 2 diabetes or obesity